Category: Pharmaceutical Information - Page 2

Venlafaxine and Blood Pressure: What You Need to Know About Hypertension Risk

Natala Menezes
|
January 23
|
9

Venlafaxine can raise blood pressure, especially at higher doses. Learn how it happens, who’s at risk, what numbers to watch for, and how to monitor safely while treating depression or anxiety.

Rheumatoid Arthritis Remission: Treat-to-Target Strategies That Work

Natala Menezes
|
January 22
|
11

Treat-to-target strategies have transformed rheumatoid arthritis care, helping over 60% of patients achieve remission through structured monitoring, regular treatment adjustments, and clear goals like DAS28 scores. This is the most effective approach backed by decades of clinical trials.

Insurance Coverage of Generic Combinations vs Individual Generics: What You Pay and Why

Natala Menezes
|
January 21
|
12

Generic combination drugs can save money-but not always. Learn how insurance plans decide between combo pills and separate generics, why you might pay more for the combo, and how to save on your prescriptions.

How to Manage Multiple Pharmacies and Prescribers Safely

Natala Menezes
|
January 19
|
11

Learn how to safely manage multiple pharmacies and prescribers for senior patients using centralized software, real-time data sync, and clinical oversight to prevent dangerous medication errors and ensure compliance.

Opioids and Adrenal Insufficiency: A Rare but Life-Threatening Side Effect You Need to Know

Natala Menezes
|
January 16
|
8

Opioid-induced adrenal insufficiency is a rare but life-threatening side effect of long-term opioid use that suppresses cortisol production. Many patients go undiagnosed until a medical crisis occurs. Early testing and awareness can prevent fatal outcomes.

Analgesic Nephropathy: How NSAIDs Damage Kidneys and What Safer Pain Relief Looks Like

Natala Menezes
|
January 15
|
12

Analgesic nephropathy is kidney damage from long-term painkiller use - often unnoticed until it's too late. Learn how NSAIDs and acetaminophen harm kidneys, who's at risk, and what safer pain relief options actually work.

DSCSA Track-and-Trace: How the U.S. Is Stopping Counterfeit Drugs Before They Reach Patients

Natala Menezes
|
January 14
|
13

The DSCSA track-and-trace system is the U.S. government's comprehensive solution to stop counterfeit drugs by requiring electronic serialization and verification at every step of the pharmaceutical supply chain, ensuring patient safety by 2024.

Rationing Medications: How Ethical Decisions Are Made During Drug Shortages

Natala Menezes
|
January 13
|
12

When life-saving drugs run out, hospitals must make tough ethical choices. This article explains how rationing works, who decides, why it often fails, and what’s being done to make it fairer during drug shortages.

When to Report Rare Side Effects from Generic Medications

Natala Menezes
|
January 11
|
11

Learn when and how to report rare side effects from generic medications. Understand the real risks, what counts as serious, and why your report matters - even if you're not a doctor.

Annual Medication Review with a Pharmacist: How It Reduces Side Effects

Natala Menezes
|
January 10
|
9

An Annual Medication Review with a pharmacist helps cut harmful side effects by checking all your meds-prescription, OTC, and supplements. Find out how it works, who needs it, and how to get one for free.

Quality and Efficacy: Are Authorized Generics as Good as Brand Drugs?

Natala Menezes
|
January 8
|
15

Authorized generics are the exact same medication as brand-name drugs, made in the same factory with identical ingredients. They work just as well, cost less, and are often safer than traditional generics. Here's what you need to know.

Meglitinides and Hypoglycemia: Why Irregular Meals Are Dangerous with These Diabetes Drugs

Natala Menezes
|
January 7
|
13

Meglitinides like repaglinide and nateglinide help control blood sugar after meals but carry high hypoglycemia risk if meals are skipped. Timing is everything-take them only when eating.